X4 Pharmaceuticals, Inc. (XFOR) Social Stream



X4 Pharmaceuticals, Inc. (XFOR): $1.71

0.22 (+14.77%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add XFOR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 384

in industry

X4 PHARMACEUTICALS INC (XFOR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering XFOR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 7 $27 $15 $19.333 $1.49 1197.52%
2021-12-14 7 $27 $11 $17.666 $1.49 1085.64%
2021-12-16 7 $27 $10 $16.833 $1.49 1029.73%
2021-12-19 7 $28 $10 $17 $1.49 1040.94%
2022-01-03 7 $28 $10 $17.333 $1.49 1063.29%
2022-03-18 7 $28 $10 $16.166 $1.49 984.97%
2022-03-21 7 $28 $10 $14.166 $1.49 850.74%
2022-05-12 7 $28 $10 $13.571 $1.49 810.81%
2022-05-13 7 $28 $8 $12.357 $1.49 729.33%
2022-05-19 7 $28 $7 $11.928 $1.49 700.54%
2022-08-04 6 $10 $5 $7.5 $1.49 403.36%
2022-08-05 6 $10 $3.5 $6.666 $1.49 347.38%
2022-09-28 6 $10 $3.5 $6.166 $1.49 313.83%

The Trend in the Analyst Price Target


Over the past 14 months, XFOR's average price target has gone down $13.26.

XFOR reports an average of 660.77% for its upside potential over the past 46 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-08 6 27 15 19.333 4.990 287.43%
2021-12-16 7 27 10 16.833 2.370 610.25%
2022-03-21 7 28 10 14.166 1.805 684.82%
2022-05-13 7 28 8 12.357 1.200 929.75%
2022-07-21 6 10 5 7.500 1.250 500%

XFOR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 6 0 0 0 0 6

The Trend in the Broker Recommendations


Over the past 62 days, XFOR's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, X4 PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 1609.72% of them.
  • In terms of how X4 PHARMACEUTICALS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1382.52% of that group.
  • In terms of how X4 PHARMACEUTICALS INC fares relative to all US stocks, note that its average analyst price target is greater than 267.04% of that group.
  • In the context of stocks in the small market cap category, X4 PHARMACEUTICALS INC's number of analysts covering the stock is higher than 1412.99% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to X4 PHARMACEUTICALS INC are VYGR, VXRT, and VOR.

Is XFOR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5905 seconds.